ChatDocto
Find a doctor
White pharmaceutical suppository

EFFERALGAN 150 mg

Paracetamol · suppositories

B/10Rectal use
3,015 DTRecorded public price · B/10
See all pack prices
Strength150 mg
Therapeutic classSYSTEME NERVEUX
ATC codeN02BE01

About this medicine

EFFERALGAN 150 mg suppositories is listed in Tunisia's medicine catalog under the active ingredient Paracetamol. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/10

    10 units in this pack

    Recorded public price3,015 DT
    AMM No.
    9133062
    CNAM code
    308501
    CNAM reference amount
    2,270 DT

    Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

    Source recorded: August 23, 2026

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formsuppositories
Route of administrationRectal use
LaboratoryIPS (Industrie Pharmaceutique Said)
OriginOriginator
ScheduleO
ATC codeN02BE01 — Paracétamol
Therapeutic classSYSTEME NERVEUX

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.

PARALVIT 150 mgSuppositoiresIPS (Industrie Pharmaceutique Said) · B/10
Recorded public price2,275 DT

Price source: CNAM — Liste des médicaments remboursables · 2026-08-04

Source recorded: August 23, 2026